{"nct_id":"NCT04659629","title":"NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2021-04-26","start_date_type":"ACTUAL","primary_completion_date":"2022-12-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NGNE"]}